Newsroom | 61671 results

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the primary analysis of the Phase 2 RAMP 201 clinical trial was published online in the Journal of Clinical Oncology (JCO). The data reported in the publication showed that avutometinib plus defactinib demonstrated a confirmed overall response rate (ORR) of 31% in all patients with recurrent low-grade...

SAN CARLOS, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Elegen, een wereldleider in DNA-productie van de volgende generatie, en Nutcracker Therapeutics, een wereldleider in RNA-ontwerp en -productie van de volgende generatie, hebben vandaag de lancering aangekondigd van een testprogramma om het eerste volledig synthetische, celvrije productieplatform voor RNA-gebaseerde gepersonaliseerde kankertherapieën (PCT's) in de industrie te demonstreren. De test markeert een nieuwe stap in de richting...

SAN CARLOS, Californie et EMERYVILLE, Californie--(BUSINESS WIRE)--Elegen, le chef de file mondial de la fabrication d’ADN de nouvelle génération, et Nutcracker Therapeutics, leader mondial de la conception et de la fabrication d’ARN de nouvelle génération, annoncent aujourd’hui le lancement d’un programme pilote visant à démontrer la première plateforme de fabrication entièrement synthétique et sans cellule de l’industrie pour les thérapies personnalisées contre le cancer à base d’ARN. Le proj...

SAN CARLOS, Calif. e EMERYVILLE, Calif.--(BUSINESS WIRE)--Elegen, un leader globale nella produzione di DNA di nuova generazione, e Nutcracker Therapeutics, un leader globale nella progettazione e produzione di RNA di nuova generazione, oggi hanno annunciato il lancio di un programma pilota per dimostrare la prima piattaforma nel settore per la produzione interamente sintetica e priva di cellule di terapie oncologiche personalizzate (PCT) a base di RNA. Il programma pilota segna un passo avanti...

SAN CARLOS, California y EMERYVILLE, California--(BUSINESS WIRE)--Elegen, líder internacional en la producción de ADN de nueva generación, y Nutcracker Therapeutics, líder internacional en el diseño y la producción de ARN de nueva generación, han anunciado hoy el lanzamiento de un programa piloto para probar la primera plataforma de fabricación totalmente sintética y sin células de la industria para terapias personalizadas contra el cáncer basadas en ARN (PCT). El programa piloto supone un paso...

SAN CARLOS, Kalifornien und EMERYVILLE, Kalifornien--(BUSINESS WIRE)--Elegen, ein führender Hersteller von DNA der nächsten Generation, und Nutcracker Therapeutics, ein weltweit führender Anbieter im Bereich RNA-Entwurf und -Herstellung der nächsten Generation, gaben heute den Start eines Pilotprogramms bekannt, um die branchenweit erste vollständig synthetische, zellfreie Herstellungsplattform für RNA-basierte personalisierte Krebstherapeutika (Personalized Cancer Therapeutics, PCTs) vorzustel...

MANHASSET, N.Y.--(BUSINESS WIRE)--A new study from researchers at Northwell Health’s Cohen Children’s Medical Center, Northwell’s Center for Gun Violence Prevention and The Feinstein Institutes for Medical Research reveals that stronger gun laws are significantly correlated with reduced firearm suicides, but socioeconomic factors play a more substantial role in firearm homicides. Published today in Journal of the American Medical Association (JAMA) Network Open, the research underscores the nee...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg...

SAN CARLOS, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden and endotoxin risks....

PARIS--(BUSINESS WIRE)--A classic ingredient in French cuisine, its popularity seems to be linked to the festive season, with the Epiphany cake: here is the almond, and more specifically the European almond, the star ingredient of healthy and sustainable cuisine. France is one of Europe's major consumers of almonds, and 50% of its imports come from Spain and Portugal. The French are particularly fond of almond flour. Last year, more than 6,400 tons of Spanish almond flour were marketed in Franc...